Adults with attention-deficit/hyperactivity disorder, or ADHD, who use an extended-release medication are more likely to continue the treatment and have a lower risk of developing substance use disorder, according to two West Virginia University studies.

Beckley Register-Herald

WVU studies find time-release medication keeps adults with ADHD on track, lowers substance use risk

Adults with attention-deficit/hyperactivity disorder (ADHD) who use an extended-release medication are more likely to continue the treatment and have a lower risk of developing substance use disorder, according to two West Virginia University studies.

Medical Xpress

Studies find time-release medication keeps adults with ADHD on track, lowers substance use risk

Attention Deficit Hyperactivity Disorder (ADHD) is no longer exclusive to childhood. More and more adults live with this diagnosis and seek effective ways to manage their symptoms. A recent global study, with more than 14,800 participants, confirmed that stimulant drugs lead the most effective treatments. However, the picture is not so simple. What does the largest study say so far? The analysis, published in January 2025 in The Lancet Psychiatr…

El Trastorno por Déficit de Atención e Hiperactividad (TDAH) ya no es exclusivo de la infancia. Cada vez más adultos conviven con este diagnóstico y buscan maneras efectivas para manejar sus síntomas. Un estudio global reciente, con más de 14.800 participantes, confirmó que los medicamentos estimulantes lideran los tratamientos más efectivos. Sin embargo, el panorama no es tan simple.  ¿Qué dice el estudio más grande hasta ahora? El análisis, pu…

Adultos con TDAH encuentran opciones en terapias personalizadas y medidas combinadas

El Tiempo Latino

Adults with ADHD find options in personalized therapies and combined measures

Newswise

Charlottesville

Albemarle County

Virginia

United States

Studies find time-release medication keeps adults

Media Bias/Fact Check

Adults with attention-deficit/hyperactivity disorder, or ADHD, who use an extended-release medication are more likely to continue the treatment and have a lower risk of developing substance use disorder, according to two West Virginia University studies. “There is a lot of information about childhood and adolescent ADHD, but very few talk about adult ADHD,” said Abdullah Al-Mamun, a data scientist and assistant professor in the WVU School of Pha…

West Virginia University

Morgantown

Monongalia County

West Virginia

On January 7, 2025, Cingulate Inc. (NASDAQ:CING) announced the successful completion of its final FDA-required study for CTx-1301 (dexmethylphenidate) aimed at treating Attention Deficit Hyperactivity Disorder (ADHD). This study, specifically a food effect study, represents a significant milestone in the development of the drug. The study involved the administration of a single 50mg dose of […]

WVU studies find time-release medication keeps adults with ADHD on track, lowers substance use risk

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics